BRAINSWAY LTD-ADR (BWAY) Fundamental Analysis & Valuation

NASDAQ:BWAY • US10501L1061

Current stock price

13.44 USD
-0.29 (-2.11%)
At close:
13.9 USD
+0.46 (+3.42%)
Pre-Market:

This BWAY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. BWAY Profitability Analysis

1.1 Basic Checks

  • BWAY had positive earnings in the past year.
  • BWAY had a positive operating cash flow in the past year.
  • In the past 5 years BWAY reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BWAY reported negative operating cash flow in multiple years.
BWAY Yearly Net Income VS EBIT VS OCF VS FCFBWAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • BWAY has a better Return On Assets (5.53%) than 80.98% of its industry peers.
  • Looking at the Return On Equity, with a value of 8.92%, BWAY belongs to the top of the industry, outperforming 80.98% of the companies in the same industry.
  • BWAY's Return On Invested Capital of 2.75% is fine compared to the rest of the industry. BWAY outperforms 70.65% of its industry peers.
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROIC 2.75%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
BWAY Yearly ROA, ROE, ROICBWAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • Looking at the Profit Margin, with a value of 12.73%, BWAY belongs to the top of the industry, outperforming 86.41% of the companies in the same industry.
  • BWAY has a Operating Margin of 5.78%. This is in the better half of the industry: BWAY outperforms 70.65% of its industry peers.
  • BWAY has a Gross Margin of 74.92%. This is amongst the best in the industry. BWAY outperforms 84.78% of its industry peers.
  • BWAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
BWAY Yearly Profit, Operating, Gross MarginsBWAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BWAY Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
  • BWAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BWAY Yearly Shares OutstandingBWAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BWAY Yearly Total Debt VS Total AssetsBWAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 3.71 indicates that BWAY is not in any danger for bankruptcy at the moment.
  • BWAY has a better Altman-Z score (3.71) than 72.28% of its industry peers.
  • The Debt to FCF ratio of BWAY is 0.37, which is an excellent value as it means it would take BWAY, only 0.37 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BWAY (0.37) is better than 91.85% of its industry peers.
  • BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.08, BWAY is in the better half of the industry, outperforming 66.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Altman-Z 3.71
ROIC/WACC0.32
WACC8.52%
BWAY Yearly LT Debt VS Equity VS FCFBWAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 3.19 indicates that BWAY has no problem at all paying its short term obligations.
  • BWAY has a Current ratio (3.19) which is comparable to the rest of the industry.
  • A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.02, BWAY is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 3.02
BWAY Yearly Current Assets VS Current LiabilitesBWAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BWAY Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 117.91% over the past year.
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%

3.2 Future

  • BWAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.61% yearly.
  • BWAY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.85% yearly.
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.37%
Revenue Next 2Y23.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BWAY Yearly Revenue VS EstimatesBWAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
BWAY Yearly EPS VS EstimatesBWAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

7

4. BWAY Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 10.42, the valuation of BWAY can be described as reasonable.
  • Based on the Price/Earnings ratio, BWAY is valued cheaply inside the industry as 92.39% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 25.79. BWAY is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 10.79, which indicates a very decent valuation of BWAY.
  • Based on the Price/Forward Earnings ratio, BWAY is valued cheaper than 92.39% of the companies in the same industry.
  • BWAY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 10.42
Fwd PE 10.79
BWAY Price Earnings VS Forward Price EarningsBWAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 66.85% of the companies are valued more expensively.
  • 97.28% of the companies in the same industry are more expensive than BWAY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.37
EV/EBITDA 41.78
BWAY Per share dataBWAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • BWAY's earnings are expected to grow with 29.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BWAY Dividend Analysis

5.1 Amount

  • No dividends for BWAY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BWAY Fundamentals: All Metrics, Ratios and Statistics

BRAINSWAY LTD-ADR

NASDAQ:BWAY (3/18/2026, 8:00:02 PM)

Premarket: 13.9 +0.46 (+3.42%)

13.44

-0.29 (-2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-11
Earnings (Next)05-11
Inst Owners5.36%
Inst Owner Change10.06%
Ins Owners15.48%
Ins Owner ChangeN/A
Market Cap263.58M
Revenue(TTM)N/A
Net Income(TTM)6.25M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short Ratio0.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)0%
PT rev (3m)3.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.5%
EPS NY rev (1m)0%
EPS NY rev (3m)5.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.81%
Revenue NY rev (1m)-3.87%
Revenue NY rev (3m)-3.87%
Valuation
Industry RankSector Rank
PE 10.42
Fwd PE 10.79
P/S 5.37
P/FCF 14.37
P/OCF 11.83
P/B 3.76
P/tB 3.76
EV/EBITDA 41.78
EPS(TTM)1.29
EY9.6%
EPS(NY)1.25
Fwd EY9.27%
FCF(TTM)0.94
FCFY6.96%
OCF(TTM)1.14
OCFY8.45%
SpS2.5
BVpS3.57
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.18
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 8.92%
ROCE 3.26%
ROIC 2.75%
ROICexc 15.43%
ROICexgc 15.43%
OM 5.78%
PM (TTM) 12.73%
GM 74.92%
FCFM 37.36%
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.37
Debt/EBITDA 1.21
Cap/Depr 207.6%
Cap/Sales 8.01%
Interest Coverage 26.28
Cash Conversion 470.69%
Profit Quality 293.55%
Current Ratio 3.19
Quick Ratio 3.02
Altman-Z 3.71
F-Score5
WACC8.52%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.68%
EPS Next Y-3.28%
EPS Next 2Y29.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.8%
Revenue Next Year23.37%
Revenue Next 2Y23.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A

BRAINSWAY LTD-ADR / BWAY Fundamental Analysis FAQ

What is the fundamental rating for BWAY stock?

ChartMill assigns a fundamental rating of 5 / 10 to BWAY.


Can you provide the valuation status for BRAINSWAY LTD-ADR?

ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.


How profitable is BRAINSWAY LTD-ADR (BWAY) stock?

BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for BWAY stock?

The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to decline by -3.28% in the next year.